Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1998
08/04/1998US5789195 Human notch and delta, binding domains in toporythmic proteins, and methods based thereon
08/04/1998US5789194 Parasitic helminth venom allergen antigen 5-like genes and proteins
08/04/1998US5789192 Mammalian receptors for interleukin-10 (IL-10)
08/04/1998US5789187 Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner
08/04/1998US5789181 Methods for identification of inhibitors of IL-1-R intracellular ligand binding
08/04/1998US5789178 Genetic engineering for antiinflammatory agents and monoclonal antibodies
08/04/1998US5789177 Glycorproteins, antibodies, and diagnostic kits for detection of bovine herpesvirus type 1
08/04/1998US5789157 Systematic evolution of ligands by exponential enrichment: tissue selex
08/04/1998US5788987 Time-specific controlled release dosage formulation
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
08/04/1998US5788969 Peptides for inducing cytotoxic T lymphocyte responses hepatitis B virus
08/04/1998US5788968 Oral administration of major histocompatibility complex antigen
08/04/1998US5788967 Composition and method for enhancing wound healing
08/04/1998US5788965 Used to treat coagulation-related disorders
08/04/1998US5788964 Method for sensitization of cancer cells for killer cell mediated lysis
08/04/1998US5788961 Superoxide dismutase
08/04/1998US5788960 Technetium-99M labeled polypeptides for imaging
08/04/1998US5788958 Using nitrous oxide synthase inhibitor
08/04/1998CA2098296C Pseudomonas peptide composition and method for producing the same
08/04/1998CA2047090C Genetic mechanisms of tumor suppression
08/04/1998CA1339980C Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
07/1998
07/30/1998WO1998033067A1 Transcription factors that repress hiv transcription and methods based thereon
07/30/1998WO1998032865A1 Novel prostate-associated kallikrein
07/30/1998WO1998032863A2 Mammalian thioredoxin
07/30/1998WO1998032861A1 Composition containing a papillomavirus e2 protein or a nucleotide sequence coding for a papillomavirus e2 protein
07/30/1998WO1998032859A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
07/30/1998WO1998032858A2 Mammalian chemokines; receptors; reagents; uses
07/30/1998WO1998032857A1 Chicken neuropeptide gene useful for poultry production
07/30/1998WO1998032855A1 Lage-1 tumor associated nucleic acids
07/30/1998WO1998032854A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
07/30/1998WO1998032853A2 Secreted proteins and polynucleotides encoding them
07/30/1998WO1998032852A1 Blnk proteins
07/30/1998WO1998032851A1 Two human homologues of galectin-5
07/30/1998WO1998032849A2 Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications
07/30/1998WO1998032846A2 Enzymatic nucleic acid treatment of diseases or conditions related to levels of c-fos
07/30/1998WO1998032841A1 Bioartificial hormone releasing device
07/30/1998WO1998032825A2 Photochemical singlet oxygen generators having enhanced singlet oxygen yields
07/30/1998WO1998032771A1 Chimeric proteins, heterodimer complexes thereof and substitute for platelet
07/30/1998WO1998032768A1 H. pylori antigens
07/30/1998WO1998032765A1 SULFAMATE DERIVATIVES WITH t-RNA SYNTHETASE INHIBITING ACTIVITY
07/30/1998WO1998032738A1 New compounds with hemoregulating effect
07/30/1998WO1998032466A1 Pegylation process
07/30/1998WO1998032461A1 Mutant enterotoxin effective as a non-toxic adjuvant for hiv
07/30/1998WO1998032460A1 Methods for diagnosing and treating body weight related disorders in animals
07/30/1998WO1998032459A1 Plasminogen activator as an anti-inflammatory agent
07/30/1998WO1998032458A1 Remedies for diabetes
07/30/1998WO1998032457A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
07/30/1998WO1998032456A1 Identification of broadly reactive dr restricted epitopes
07/30/1998WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate
07/30/1998WO1998032448A1 Facilitation of repair of neural injury with cm101/gbs toxin
07/30/1998WO1998032446A1 Urease-responsive delivery systems for diagnostic and therapeutic applications
07/30/1998WO1998032435A1 Liquid eye drop composition
07/30/1998WO1998032427A1 Therapeutic treatment and prevention of infections with a bioactive material encapsulated within a biodegradable-biocompatible polymeric matrix
07/30/1998WO1998032425A1 Pharmaceutical formulations with delayed drug release
07/30/1998WO1998032423A1 Sustained-release microspheres, their production and use
07/30/1998WO1998032333A1 Improved chondrogenic differentiation of human mesenchymal stem cells
07/30/1998WO1998024814A3 N-terminally modified polypeptide enzyme inhibitors, and related therapeutic methods and pharmaceutical compositions
07/30/1998WO1998024478A3 Tumour therapy
07/30/1998WO1998023775A3 DNA for evaluating the progression potential of cervical lesions
07/30/1998WO1998023286A3 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy
07/30/1998WO1998022508A3 Process for tumour cell depletion of cd34-positive cells
07/30/1998WO1998022499A3 Arretin, a neurite outgrowth modulator, antibodies thereto and uses thereof
07/30/1998WO1998022131A3 Modulators of ovarial apoptosis related to IAP
07/30/1998WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity
07/30/1998WO1998020130A3 Secreted proteins and polynucleotides encoding them
07/30/1998WO1998017687A3 Secreted proteins and polynucleotides encoding them
07/30/1998WO1998017684A3 DNA sequences encoding fusions of DNA repair proteins and uses thereof
07/30/1998WO1998017313A3 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
07/30/1998WO1998011130A3 Mammalian ependymin-like proteins
07/30/1998WO1998010787A3 Pharmaceutical compositions for the treatment of immune disorders
07/30/1998WO1997048723A3 Ptp-20, pcp-2, bdp1, clk and sirp proteins and related products
07/30/1998CA2456777A1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
07/30/1998CA2279260A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
07/30/1998CA2279241A1 Mammalian thioredoxin
07/30/1998CA2278823A1 Plasminogen activator as an anti-inflammatory agent
07/30/1998CA2278770A1 Secreted proteins and polynucleotides encoding them
07/30/1998CA2278737A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
07/30/1998CA2278663A1 Urease-responsive delivery systems for diagnostic and therapeutic applications
07/30/1998CA2278623A1 Novel prostate-associated kallikrein
07/30/1998CA2278621A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
07/30/1998CA2278463A1 Two human homologues of galectin-5
07/30/1998CA2278451A1 Chicken neuropeptide gene useful for poultry production
07/30/1998CA2278296A1 Identification of broadly reactive dr restricted epitopes
07/30/1998CA2278152A1 Treatment of autoimmune disease using tolerization in combination with methotrexate
07/30/1998CA2277955A1 Remedies for diabetes
07/30/1998CA2277821A1 Photochemical singlet oxygen generators having enhanced singlet oxygen yields
07/30/1998CA2276691A1 Methods for diagnosing and treating body weight related disorders in animals
07/30/1998CA2250291A1 Chimeric proteins, their heterodimer complexes, and platelet substitutes
07/30/1998CA2228017A1 A drug preparation for oral administration
07/29/1998EP0855444A2 Aspartic proteinase 2 (ASP2)
07/29/1998EP0855443A2 cDNA clone HE8CH90 that encodes a 7-transmembrane receptor
07/29/1998EP0855442A2 Central nervous system transcription regulator polypeptide and a DNA sequence to which a protein containing the polypeptide binds
07/29/1998EP0855404A1 Interleukin-1 receptor antagonist beta (il-1rabeta)
07/29/1998EP0855185A2 Host-vector system for use in gene therapy
07/29/1998EP0855024A1 Histone deacetylase as target for antiprotozoal agents
07/29/1998EP0854930A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof
07/29/1998EP0854928A2 Multi-functional hematopoietic receptor agonists
07/29/1998EP0854927A1 Human dnase i variants
07/29/1998EP0854924A1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
1 ... 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 ... 3163